Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aerobic glycolysis refers to the metabolic pathway in which glucose is converted to pyruvate with the concurrent generation of ATP, even in the presence of sufficient oxygen to support oxidative phosphorylation. Unlike the classic model where glucose is fully oxidized through the citric acid cycle under aerobic conditions, some cells (notably cancer cells and activated immune cells) preferentially metabolize glucose to lactate despite oxygen availability—a phenomenon called the Warburg effect. The pathway involves a sequence of enzymatic reactions (including hexokinase, phosphofructokinase-1, and pyruvate kinase) and is crucial for rapid ATP production, biosynthesis, and cellular proliferation. As a complex pathway rather than a single target, therapeutic strategies aim at inhibiting specific glycolytic enzymes rather than the pathway as a whole.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aerobic glycolysis pathway (null).